Sarasin & Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.14M Buy
+15,100
New +$2.43M 0.02% 88

Other funds holding NBIX

Sarasin & Partners's NBIX Position: Q3 2026 in Review

Sarasin & Partners opened a new position in Neurocrine Biosciences (NBIX) in Q3 2026: 15,100 shares worth $2.14M. The stake represents 0.02% of the portfolio and ranks #88 among its holdings.

771 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.

  • Sarasin & Partners held 15,100 shares of Neurocrine Biosciences worth $2.14M as of Q3 2026.
  • Neurocrine Biosciences was a new Sarasin & Partners position in Q3 2026.
  • Neurocrine Biosciences made up 0.02% of Sarasin & Partners's portfolio in Q3 2026, its #88 holding.
  • 771 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.

Based on Sarasin & Partners's 13F filing for Q3 2026, filed 13 Oct 2026.